Testing effectiveness (Phase 2)Study completedNCT04681430
What this trial is testing
Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals
Who this might be right for
Corona Virus InfectionSARS-CoV-2 InfectionSARS-CoV-2 PCR Test Positive+1 more
Heinrich-Heine University, Duesseldorf 22